Safe Harbor: This presentation contains forward-looking statements made pursuant to the
safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements
are based on management's current expectations and are subject to risks and uncertainties that
could cause actual results to differ materially from those described in the forward-looking
statements. These risks and uncertainties are contained in the Corporation's filings with the
Securities and Exchange Commission and include: information of a preliminary nature that may
be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new
products, governmental restrictions on the sale of certain products, dependence on key
personnel, development by competitors of new or superior products or cheaper products or new
technology for the production of products, the entry into the market of new competitors, market
and customer acceptance and demand for new pharmaceutical products, availability of raw
materials, timing and success of product development and launches, integrity and reliability of the
Corporation's data, compliance with regard to regulatory and cGMP managing our recent rapid
growth and anticipated future growth, occasional credits to certain customers reflecting price
reductions on products previously sold to them and still available as a shelf- stock adjustment,
possibility of an incorrect estimate of chargebacks and the impact of such an incorrect estimate
on net sales, gross profit and net income, dependence on few products generating majority of
sales, product liability claims for which the Company may be inadequately insured, subjectivity in
judgment of management in applying certain significant accounting policies derived based on
historical experience, terms of contracts, accounts receivable allowances including chargebacks,
rebates, income taxes, values of assets and inventories, litigation involving claims of patent
infringement, litigation involving claims for royalties, and other risks identified in this report and
identified from time to time in our reports and registration statements filed with the Securities and
Exchange Commission. These forward-looking statements represent our judgment as of the date
of this report. We disclaim, however, any intent or obligation to update our forward-looking
statements.
